Monthly Archives: January 2021

DUBLIN--(BUSINESS WIRE)--The "Global Veterinary Research Laboratory (VRL) Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

According to a report, the global market for veterinary research laboratory (VRL) is predicted to progress at a CAGR of 10.63% during the estimated years of 2021-2028.

Factors such as surging zoonotic diseases, coupled with a rise in animal healthcare spending, are stimulating the growth of the veterinary research laboratory (VRL) market. Further, the technological advancements in animal healthcare and rising government initiatives to promote animal health, are generating new opportunities for the veterinary research laboratory market during the assessed period.

However, the lack of standardized regulations pertaining to animal healthcare and a dearth of skilled veterinary professionals in underdeveloped countries, are restricting the expansion of the veterinary research laboratory (VRL) market.

The global veterinary research laboratory (VRL) market covers the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.

The Asia-Pacific is predicted to become the fastest-evolving market for veterinary research laboratory during the period 2021-2028. In the region, the market's growth is likely to be driven by high investment in R&D, along with multiple initiatives taken by prominent market players to commercialize veterinary hematology and immunodiagnostic products at low prices.

For instance, in China, the high number of manufacturing facilities, growing investments by key players, and surge in animal healthcare expenditure is opening avenues for the studied market. Above all, the increase in awareness among pet owners regarding early diagnosis and treatment of diseases in companion animals, is adding to the growth of the veterinary research laboratory market.

Companies Mentioned

Key Topics Covered:

1. Global Veterinary Research Laboratory (VRL) Market - Summary

2. Industry Outlook

2.1. Market Definition

2.3. Impact of Covid-19 on Veterinary Research Laboratory (VRL) Market

2.4. Legal, Policy, & Regulatory Framework

2.5. Key Insights

2.6. Market Attractiveness Index

2.7. Vendor Scorecard

2.8. Market Drivers

2.8.1. Surging Zoonotic Diseases

2.8.2. Rise in Animal Healthcare Expenditure

2.9. Market Restraints

2.9.1. Lack of Standardized Regulations Pertaining to Animal Healthcare

2.9.2. Lack of Skilled Veterinary Professionals in Underdeveloped Nations

2.10. Market Opportunities

2.10.1. Technological Advancements in Animal Healthcare

2.10.2. Growing Government Initiatives to Promote Animal Health

3. Global Veterinary Research Laboratory (VRL) Market Outlook - by Application

3.1. Clinical Pathology

3.2. Productivity Testing

3.3. Toxicology

3.4. Other Applications

4. Global Veterinary Research Laboratory (VRL) Market Outlook - by Technology

4.1. Clinical Chemistry

4.2. Immunodiagnostics

4.2.1. Elisa

4.2.2. Lateral Flow Rapid Tests

4.2.3. Other Immunodiagnostics

4.3. Hematology

4.4. Molecular Diagnostics

4.4.1. Pcr

4.4.2. Microarrays

4.4.3. Other Molecular Diagnostics

4.5. Other Technologies

5. Global Veterinary Research Laboratory (VRL) Market Outlook - by Animal Type

5.1. Production Animals

5.1.1. Cattles

5.1.2. Poultry

5.1.3. Pigs

5.1.4. Sheep and Goats

5.1.5. Other Production Animals

5.2. Companion Animals

5.2.1. Cats

5.2.2. Dogs

5.2.3. Horses

5.2.4. Other Companion Animals

6. Global Veterinary Research Laboratory (VRL) Market - Regional Outlook

6.1. North America

6.2. Europe

6.3. Asia-Pacific

6.4. Latin America

6.5. Middle East and Africa

7. Company Profile

7.1. Biomerieux Sa

7.2. Royal Gd Animal Health

7.3. Indical Bioscience GmbH

7.4. Thermo Fisher Scientific Inc

7.5. Neogen Corporation

7.6. Zoetis

7.7. Bio-Rad Laboratories Inc

7.8. Boehringer Ingelheim Animal Health GmbH

7.9. Virbac Sa

7.10. Idexx Laboratories

7.11. Nutreco Nv

7.12. Texas A&M Veterinary Medical Diagnostic Laboratory

7.13. Vca Inc (Acquired by Mars)

7.14. Protatek International Inc

8. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/al3xgv

See the article here:

Worldwide Veterinary Research Laboratory (VRL) Industry to 2028 - by Application, Technology, Animal Type and Region - ResearchAndMarkets.com -...

Like every year, the Largus jury honors a sporting feat, a technology, a concept car or a commercial performance.For the 2021 edition, Renaults E-TECH hybrid and plug-in hybrid technology won unanimous support.

Developed and patented by Renault engineering, E-TECH hybrid technology combines two electric motors, a heat engine and an ingenious transmission inspired by Formula 1, without clutch and without synchronizer.This unique system is also the result of the brands know-how for more than 10 years in electric mobility.

Renaults hybrid technology makes it possible to drive electric vehicles up to 80% of the time in town and to reduce fuel consumption by up to 40% on an E-TECH Hybrid engine.It allows you to drive up to 65 km in electric power in the city (WLTP City) and to enjoy the approval of the electric motor up to 135 km / h on an E-TECH Plug-in Hybrid motor.

By deploying this modular hybrid technology on these core-range vehicles, Renault intends to democratize the electric experience and its advantages: systematic electric starts, responsiveness, regeneration of the battery during deceleration and braking, reduction of CO2, savings in consumption.Launched in 2020, E-TECH hybrid powertrains are already equipping Clio with hybrid, Captur and Mgane Estate with plug-in hybrids.Captur is thus the most accessible plug-in of the B-SUV segment.3 new versions will be added to the Renault range in 2021, with Arkana and Captur as a hybrid and Mgane as a plug-in hybrid.

The award, a trophy made from a camshaft, was presented to Groupe Renault Engineering Director, Gilles Le Borgne, on behalf of all the teams that carried out this innovative project.

I am very honored to receive the Special Jury Prize for our E-TECH hybrid technology because it is the fruit of long-term work for the teams who have carried out this project for almost 10 years.To achieve this, the Renault teams have filed more than 150 patents, notably on the clutch box, the heart of the systems innovation.This innovative technology offers exceptional CO2 efficiency with a remarkable customer experience.

Gilles Le Borgne, Director of Engineering at Groupe Renault

SOURCE:Renault

Originally posted here:

Renault's revolutionary hybrid E-TECH technology spotlight in the 2021 Argus Trophies - Automotive World

New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "NDT & Inspection Market Research Report by Testing Technology, by Type, by Vertical - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06018559/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global NDT & Inspection Market is expected to grow from USD 8,793.10 Million in 2020 to USD 12,424.31 Million by the end of 2025.2. The Global NDT & Inspection Market is expected to grow from EUR 7,709.96 Million in 2020 to EUR 10,893.87 Million by the end of 2025.3. The Global NDT & Inspection Market is expected to grow from GBP 6,854.17 Million in 2020 to GBP 9,684.68 Million by the end of 2025.4. The Global NDT & Inspection Market is expected to grow from JPY 938,447.07 Million in 2020 to JPY 1,325,989.41 Million by the end of 2025.5. The Global NDT & Inspection Market is expected to grow from AUD 12,768.75 Million in 2020 to AUD 18,041.76 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the NDT & Inspection to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Testing Technology, the NDT & Inspection Market studied across Eddy Current Testing, Liquid Penetrant Testing, Magnetic Particle Testing, Radiography Testing, Ultrasonic Testing, and Visual Inspection Testing.

Based on Type, the NDT & Inspection Market studied across Equipment and Services. The Services further studied across Calibration services, Equipment Rental Services, Inspection Services, and Training Services.

Based on Vertical, the NDT & Inspection Market studied across Aerospace, Automotive, Manufacturing, Marine, Medical & Health, Oil & Gas, Plastics & Polymers, Power Generation, and Public Infrastructure.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the NDT & Inspection Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the NDT & Inspection Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global NDT & Inspection Market including Applus Services, S.A, Ashtead Technology Ltd., Aurora Capital Group LLC, British Engineering Services Limited, Bureau Veritas SA, Duemme S.P.A, Eddyfi NDT Inc., Fischer Technology, Inc., FUJIFILM Corporation, Geecy Apave Pvt. Ltd., General Electric Company, Intertek Group PLC, Magnaflux Corporation, Mistras Group, Inc., Nikon Corporation, Olympus Corporation, Sigma NDT Service, Sonatest Ltd, Td Williamson, Inc, TEAM Inc., and Yxlon International GmbH by InVision Technologies, Inc..

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the NDT & Inspection Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global NDT & Inspection Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global NDT & Inspection Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global NDT & Inspection Market?4. What is the competitive strategic window for opportunities in the Global NDT & Inspection Market?5. What are the technology trends and regulatory frameworks in the Global NDT & Inspection Market?6. What are the modes and strategic moves considered suitable for entering the Global NDT & Inspection Market?Read the full report: https://www.reportlinker.com/p06018559/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

See more here:

NDT & Inspection Market Research Report by Testing Technology, by Type, by Vertical - Global Forecast to 2025 - Cumulative Impact of COVID-19 -...

[co-author: Mostafa Al Khonaizi ]

Hydrogen is not found freely in the atmosphere, and the pathways of producing hydrogen differ significantly in their carbon intensity. These pathways are typically referred to by colors grey, blue, and green based on the various inputs required to produce the hydrogen, with conventional means of producing hydrogen emitting most significant carbon dioxide into the atmosphere.

Grey hydrogen is produced using fossil fuel hydrocarbon feedstocks, most typically, natural gas. As such, it is the most carbon-intensive pathway of generating hydrogen. The conventional methods use either steam methane reforming or autothermal reforming processes to separate hydrogen from carbon and make up about 75% of total hydrogen production.1 Coal is also sometimes used in a gasification process to produce hydrogen, among other chemicals. The cost of these methods of producing grey hydrogen is low, ranging from less than $1 to $2 per kilogram of hydrogen,2 depending on the cost of natural gas or coal, but no carbon emissions are captured during these processes, contributing to the carbon intensity of this means of production.

Blue hydrogen is produced through the same conventional processes as grey hydrogen discussed above. However, these processes are augmented with carbon capture utilization and sequestration technologies (CCUS) to catch the emitted carbon and store it for other uses before it makes its way into the atmosphere.

Governments are providing incentives for grey hydrogen producers to install CCUS units to control carbon emissions and meet decarbonization goals. The U.S. Government offers CCUS tax credits for qualified CCUS equipment owners. However, CCUS adds about half a dollar per kilogram to the cost of conventional grey hydrogen processes, resulting in a range of $1.5 to $2.5, final price depending on the cost of natural gas or coal input.3

Electrolyzers are used to produce green hydrogen from electricity generated using renewable, carbon-free sources of energy such as wind and solar. To date, there are no green hydrogen plants operating at commercial scale in the United States, but there are several pilot and demonstration projects in the pipeline.4 Unlike grey and blue hydrogen, the costs of which rely on commodity prices, the cost of green hydrogen is a function of several variables including (1) plant utilization rates, (2) power prices of renewable sources (the levelized cost of energy, LCOE), (3) electrolyzer efficiency, and (4) electrolyzer manufacturing costs.5

With the current technology and efficiency of electrolyzers, the cost of one kilogram of green hydrogen can range from $3 to $8, depending on the LCOE.6 However, the LCOE of renewables is still relatively high compared to traditional electricity sources, putting the actual base cost of green hydrogen well above $4, even in most optimal situations (i.e., solar electricity from the best geographic locations with high utilization rate).7 In short, green hydrogen currently costs at least four times more than grey hydrogen from the conventional pathways.

Besides these three pathways or colors there are other potential pathways such as pink where hydrogen is generated by electrolysis using nuclear energy but their current production capacities and technologies make them far less appealing to any decarbonization plan.

Most hydrogen is used in industry (e.g., in refining oil and producing fertilizers), and it has been produced in close proximity to and in quantities aligned with actual demand of such industries, therefore eliminating the need for long-distance transmission. However, for hydrogen to become a viable part of the transportation fuel infrastructure (among other possible uses), moving and storing hydrogen at disperse locations will become necessary.

Hydrogen is mainly stored in a gaseous or liquid form in storage tanks. Some of hydrogens qualities make it difficult to transport and store at scale. For example, it is highly reactive, so it requires careful handling, and it has low energy density, thus requiring high pressure systems or a much larger space for economical storage and transportation. Ammonia could be used for storing and transporting hydrogen over long-distance, as it contains twice as much hydrogen as liquid hydrogen by volume and has a higher liquification temperature. A fleet of refrigerated ammonia transportation vessels already exists as well. However, the conversion and re-conversion processes of ammonia require energy and, therefore, impose a significant efficiency toll in the hydrogen lifecycle. Finally, the current natural gas pipeline infrastructure is unsuitable for hydrogen transportation without significant upgrades,8 and blending hydrogen with the current natural gas flow, up to a threshold of 20%, is possible but would accelerate infrastructure deterioration.9 Nonetheless, a dedicated hydrogen pipeline network would present significant financial and logistical challenges to the widespread distribution of hydrogen for non-industrial applications.

The carbon intensity of hydrogen use is dependent on whether grey, blue, or green hydrogen is being utilized, as the different production processes differ dramatically in their effectiveness as low-carbon energy solutions. Currently, cost, technology, and infrastructure constraints inhibit the expansive development and utilization of green hydrogen. Developers with innovative technology could attempt to develop pilot projects and then commercial scale projects in an attempt to overcome some of these constraints. Our next article in this series will explore possible structures for the development of a hydrogen project.

*Mostafa Al Khonaizi is a law clerk in our New York office.

1 Goldman Sachs, Carbonomics: The Rise of Clean Hydrogen, at 11 (Equity Research, July 2020).

2 Wood Mackenzie, Future Energy: The Technologies Shaping The Energy Transition, at 4 (2020); Jay Bartlett & Alan Krupnick, Decarbonized Hydrogen in the US Power and Industrial Sectors: Identifying and Incentivizing Opportunities to Lower Emissions, Resources for the Future, at 10 (Dec. 2020) Goldman Sachs, supra note 1, at 17, exhibit 22.

3 Id.

4 International Renewable Energy Agency (IRENA), Green Hydrogen Cost Reduction, sec. 5, at 82-85 (2020).

5 See id.; Wood Mackenzie, supra note 2, at 4.

6 See supra note 2.

7 See supra note 2.

8 Unsuitable due to, among other things, pipe embrittlement and leakage (material integrity) and incompatibility with end-use systems/appliances. For a detailed report on blending hydrogen into the natural gas pipeline, see M. W. Melaina et al., Blending Hydrogen into Natural Gas Pipeline Networks: A Review of Key Issues, National Renewable Energy Laboratory (March 2013).

9 National Renewable Energy Laboratory: News, HyBlend Project To Accelerate Potential for Blending Hydrogen in Natural Gas Pipelines (Nov. 18, 2020). See Christopher Findlay, Whats your purpose? Reusing Gas Infrastructure for Hydrogen Transportation, Siemens Energy (Sept. 11, 2020).

Read the original here:

Hydrogen Production Technology And Infrastructure Restrictions | Vinson & Elkins LLP - JDSupra - JD Supra

The global robotic rehabilitation and assistive technologies market is likely to witness robust growth owing to the increasing incidences of limited mobility amongst many people. Rehabilitation robotics and assistive technologies enable utilization of robotic devices for the purpose of recovery of patients affected with limited mobility. This technology enables robotic applications to be used in therapeutic processes to assist in the recovery of patients suffering from spinal cord injury, orthopedic traumas, strokes, neuromotor disorders, and cognitive diseases. This type of robots enable people affected with degenerative cognitive and motor capabilities lead a self-dependent life.

The global robotic rehabilitation and assistive technologies market has been segmented based on product type, portability, application, and region. The main of such a comprehensive report is to provide a deeper understanding into the market.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6191

Global Robotic Rehabilitation and Assistive Technologies Market: Notable Developments

The global robotic rehabilitation and assistive technologies market has witnessed quite a few developments over the last few years. One such development is mentioned below:

Some of the leading market players of the global robotic rehabilitation and assistive technologies market are

Global Robotic Rehabilitation and Assistive Technologies Market: Growth Drivers

Increased Prevalence of Various Types of Disabilities to Bolster its Demand

The global robotic rehabilitation and assistive technologies market is expected to thrive on the increased need of people with mobility challenges to lead an independent life. Modern technology in robotics is helping in making the lives of disabled people easier. It is also making the functionalities of their body better.

Well-designed technology to develop companionship and care robots together with assistive speech technology is likely to propel the growth of the global robotic rehabilitation and assistive technologies market. The stakeholders are carrying on research and development to figure out how assistive robots are capable of effectively assisting differently able people. They are trying to find out ways to design innovative robots that would help them overcome the challenges of limited mobility.

Innovations such as robotic trousers are helping patients walk normally. These trousers are developed utilizing soft artificial muscles that are conditioned electrically to instigate bodily movements like standing up. Innovations such as this are likely to open up new avenues of growth for the global robotic rehabilitation and assistive technologies market in years to come.

Global Robotic Rehabilitation and Assistive Technologies Market: Regional Outlook

In terms of region, North America is estimated to account for a large chunk of the global robotic rehabilitation and assistive technologies market over the timeframe of forecast. Such dominance of the region is driven by the adoption of highly advanced robotic rehabilitation & assistive technologies. In addition, favorable reimbursement policies from the healthcare industry are likely to emerge as another important growth factor for the market in the region.

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6191

The global robotic rehabilitation and assistive technologies market is segmented as:

Product Type

Portability

Application

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/

Visit link:

Robotic Rehabilitation and Assistive Technologies Market | Top Trends and Growth Opportunities Analysis - BioSpace

The Zephyr Valve was approved by the FDA in 2018

by: Keely Lovern

YOUNGSTOWN, Ohio (WKBN) Mercy Health is bringing new technology to the Valley to help people with chronic lung illnesses.

Its a new type of therapy that uses whats called the Zephyr Valve. The device was approved by the FDA in 2018.

Mercy Health says its exciting because its the first less-invasive option for patients with severe emphysema and COPD.

Until now, the closest availability for this treatment was in Erie, Pennsylvania.

I think hope is an important thing as we know were living through a current pandemic, so anything that you can offer patients who again would love to play with their grandkids or be able to go to the store without being limited is a huge benefit to how people live their daily lives, said Dr. Timothy Barreiro, a pulmonologist at St. Elizabeth Youngstown Hospital. The ability to do that here, local, in trained hands will be a nice thing to offer them.

Dr. Barreiro says this therapy is not for everyone though. He adds that only about 30% of patients meet the necessary criteria, but they do have several other options to help patients with lung illnesses.

Read the original:

Mercy Health offering new technology to help those with severe lung illnesses - WKBN.com

For Immediate Release

Chicago, IL January 29, 2021 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corporation NVDA, Verizon Communications, Inc. VZ, AstraZeneca PLC AZN, Micron Technology, Inc. MU and Anthem, Inc. ANTM.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, Verizon Communications and AstraZeneca. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can seeall oftoday'sresearch reports here >>>

NVIDIAshares have outperformed the Zacks General Semiconductor industry over the past year (+110.4% vs. +28.8%), as the company benefited from the coronavirus-induced work-from-home and learn-at-home wave. It is also benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues.

Moreover, a surge in Hyperscale demand remains a tailwind for the company's Data Center business. Expansion of NVIDIA GeForce NOW is expected to drive user base. Further, solid uptake of AI-based smart cockpit infotainment solutions is a boon.

Additionally, collaboration with Daimler-owned Mercedes-Benz is expected to further strengthen NVIDIA's presence in the autonomous vehicles and other automotive electronics space. However, management expects COVID-19 pandemic to negatively impact near-term revenues by $100 million. Moreover, the U.S.-China trade war remains a key concern.

(You canread the full research report on NVIDIA here >>>)

Shares ofVerizonhave lost -4.1% in the last six months against the Zacks Wireless National industry's gain of +5.9%. The Zacks analyst believes that adoption of unlimited data plans has resulted in reduction of wireless service revenues. Hefty expenses on promotion and lucrative discounts to attract customers, further hampers its profitability.

Story continues

Verizon reported relatively solid fourth-quarter results with the top and bottom line beating the respective Zacks Consensus Estimate driven by a disciplined network strategy and focused roadmap for technology leadership. It expects to witness solid 5G momentum backed by customer-centric business model and diligent execution of operational plans.

Verizon is aiming to augment its mid-band spectrum capacity to support the evolving customer behavior. The company has offered a bullish guidance based on the resilient earnings performance and projected trends. However, Verizon operates in an intensely competitive U.S. wireless market that strains margins.

(You canread the full research report on Verizon here >>>)

AstraZenecashares have gained +2% over the past three months against the Zacks Large Cap Pharmaceuticals industry's rise of +15.4%. The Zacks analyst believes that AstraZeneca's products like Nexium, Crestor and Seroquel are facing generic competition, which is hurting sales.

The diabetes franchise also faces stiff competition while pricing pressure is hurting sales in the respiratory unit. Nonetheless, AstraZeneca's cancer medicines Lynparza, Tagrisso and Imfinzi should keep driving revenues. Its pipeline is strong with several phase III data readouts lined up. Its COVID-19 vaccine candidate, AZD1222 has progressed at a rapid pace.

AstraZeneca has also engaged in external acquisitions and strategic collaborations to boost its pipeline while investing in geographic areas of high growth like China. Its shares have underperformed the industry in the past six months. The company has a mixed record of earnings surprises in recent quarters. Estimates have gone down slightly ahead of Q4 earnings release.

(You canread the full research report on AstraZeneca here >>>)

Other noteworthy reports we are featuring today includeMicron Technology and Anthem.

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot stocks we're targeting >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumedthat any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein andis subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportVerizon Communications Inc. (VZ) : Free Stock Analysis ReportMicron Technology, Inc. (MU) : Free Stock Analysis ReportNVIDIA Corporation (NVDA) : Free Stock Analysis ReportAstraZeneca PLC (AZN) : Free Stock Analysis ReportAnthem, Inc. (ANTM) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research

See the original post here:

The Zacks Analyst Blog Highlights: NVIDIA, Verizon, AstraZeneca, Micron Technology and Anthem - Yahoo Finance

New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Tissue Ablation Market Research Report by Technology, by Indication, by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06018567/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Tissue Ablation Market is expected to grow from USD 15,706.23 Million in 2020 to USD 21,630.47 Million by the end of 2025.2. The Global Tissue Ablation Market is expected to grow from EUR 13,771.52 Million in 2020 to EUR 18,966.01 Million by the end of 2025.3. The Global Tissue Ablation Market is expected to grow from GBP 12,242.91 Million in 2020 to GBP 16,860.82 Million by the end of 2025.4. The Global Tissue Ablation Market is expected to grow from JPY 1,676,253.67 Million in 2020 to JPY 2,308,519.93 Million by the end of 2025.5. The Global Tissue Ablation Market is expected to grow from AUD 22,807.54 Million in 2020 to AUD 31,410.32 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Tissue Ablation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the Tissue Ablation Market studied across Cryoablation, Electrical Ablation, Hydromechanical Ablation, Light/Laser Ablation, Microwave Ablation, Radiofrequency (RF) Ablation, and Ultrasound Ablation.

Based on Indication, the Tissue Ablation Market studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.

Based on Type, the Tissue Ablation Market studied across Minimally Invasive Surgery and Open Surgery.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Tissue Ablation Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Tissue Ablation Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Tissue Ablation Market including Abbott Laboratories, Alcon Inc., Alpinion Medical System, Angiodynamics, Inc., Atricure, Inc., Biosense Webster Inc., Boston Scientific Corporation, C.R Bard Inc., Chongqing Haifu Medical Technology Co., Ltd., Conmed Corporation, EDAP TMS, Ethicon, Inc., Galil Medical, Inc., HealthTronics, Inc., HS Hospital Service S.P.A, IceCure, Johnson & Johnson, Medtronic PLC, Mermaid Medical, Misonix, Inc., NeuWave Medical, Inc., Olympus Corporation, Shanghai A&S Science Technology Development, Smith & Nephew Plc, SonaCare Medical LLC., St Jude Medical, Stryker Corporation, and Theraclion.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Tissue Ablation Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Tissue Ablation Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Ablation Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Ablation Market?4. What is the competitive strategic window for opportunities in the Global Tissue Ablation Market?5. What are the technology trends and regulatory frameworks in the Global Tissue Ablation Market?6. What are the modes and strategic moves considered suitable for entering the Global Tissue Ablation Market?Read the full report: https://www.reportlinker.com/p06018567/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Visit link:

Tissue Ablation Market Research Report by Technology, by Indication, by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire

The human impact of COVID-19 on cancer care was summed up by Dr Tristan Cope, Medical Director at the Aintree University Hospitals NHS Foundation Trust. Its devastating for the patient if theyve come into a hospital, expecting to have a potentially life-saving cancer operation and, that morning, are told it cant go ahead, he stated.

Dr Hopes words get to the crux of the issue facing cancer care teams across the UK. The first wave of the pandemic created a worrying backlog; Cancer Research UK estimated that 12,750 fewer cancer patients had had surgery, 6,000 fewer had received chemotherapy, and 2,800 fewer had had radiotherapy due to the postponement of routine NHS care.

These findings will only have been exacerbated by the current crisis. Cancer charity Action Radiotherapy recently stated that cancer services would need to be working at around 120% to clear the backlog over the next two years. But without any extra funding for new, smarter equipment, the problem could take until 2025 to clear. Professor Pat Price, Chair of Action Radiotherapy, said: The message to the government is that you have really got to invest now, just get on with it and put some money behind it and respond to these smart solutions that are available. One of these smart solutions is AI-based technology, which has an important role to play in making cancer treatment more effective and efficient.

It is important to note that many hospitals have been innovative in their approach to delivering cancer care during the pandemic. Many are using hypofractionation regimes to optimise the delivery of radiotherapy. Hypofractionation is a technique where patients are given a smaller number of radiation treatments at a higher dosage rate. By reducing the number of sessions and hospital visits, treatment is faster, while also minimising patient exposure to COVID.

However, more powerful doses require greater precision. This is where Artificial Intelligence (AI) has an important role to play.

AI technology can automate and improve the time-consuming and skill-intensive task of outlining organs at risk. This ensures that healthy tissue is not impacted by radiotherapy treatment, a critical process given the higher doses delivered under hypofractionation regimes

Discussing the impact of AI Autocontouring technology, Angela Rubio, former Chief Medical Dosimetrist at the University of New Mexico Cancer Centre stated that: Prior to using AI, contouring for a head and neck cancer patient would take about two hours to complete. With autocontouring it takes about 30 minutes. That is a 75% time-saving for each head and neck patient. Essentially the technology is saving us seven hours a week; almost a full working day.

The widespread use of AI autocontouring has the potential to deliver similar efficiencies across NHS cancer clinics. This would enable time-pressured healthcare teams to treat more patients and tackle the COVID backlog.

The potential of AI autocontouring to enhance cancer treatment has been recognised by the UK government. Secretary of State for Health Matt Hancock stated that: the NHS is committed to fast-tracking pioneering AI technologies to the front line, freeing up clinicians time and saving lives. As part of this commitment, the NHS recently announced a 140m AI in Health and Care Award programme. It was positive to note that one of the key awards focused on progressing AI-based medical imaging.

While the government and healthcare practitioners recognise the value of AI autocontouring in cancer care, getting these solutions into the hands of frontline staff presents a major challenge. NHS staff are stretched to the limit as they tackle COVID whilst trying to minimise the impact on cancer treatment.

Dr Rob Chuter, Principal Clinical Scientist at The Christie NHS Foundation Trust, states that additional support is needed to deliver AI technologies more widely. Adopting and implementing new technologies into NHS infrastructure is a complex task requiring both investment and training. Clinicians just do not have the time for this at the moment, they are too busy to step off the conveyor belt. We need more resources for training and development to integrate AI technologies into cancer care, he states.

In response to this challenge, some of the companies developing AI autocontouring solutions are launching NHS Accelerator Programmes. These are designed to fast-track access to this technology at this critical juncture. Accelerators can significantly reduce the time taken for AI autocontouring to be live in clinics as well as providing hands-on support to upskill clinicians.

As we have seen, investment in AI technology has an important role to play in supporting the NHS as it seeks to maintain cancer care services and tackle the COVID backlog. However, the adoption of technology into the cancer care workflow is also an important building block for the future of cancer treatment in the UK. All predictions indicate unprecedented future demand for cancer care; Cancer Research UK projects a 40% increase in cases by 2025. By embedding AI technology into cancer care now, the NHS can ensure that one of the legacies of COVID is a more efficient and effective treatment system for the future.

Editor's Recommended Articles

More here:

AI technology can help tackle the cancer care backlog - Open Access Government

New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Grow Light Market Research Report by Installation, by Technology, by Spectrum, by Watt, by Lighting Type, by Product, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06015746/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Grow Light Market is expected to grow from USD 1,807.55 Million in 2020 to USD 3,300.77 Million by the end of 2025.2. The Global Grow Light Market is expected to grow from EUR 1,584.90 Million in 2020 to EUR 2,894.18 Million by the end of 2025.3. The Global Grow Light Market is expected to grow from GBP 1,408.98 Million in 2020 to GBP 2,572.93 Million by the end of 2025.4. The Global Grow Light Market is expected to grow from JPY 192,912.17 Million in 2020 to JPY 352,276.41 Million by the end of 2025.5. The Global Grow Light Market is expected to grow from AUD 2,624.81 Million in 2020 to AUD 4,793.16 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Grow Light to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Installation, the Grow Light Market studied across New Installation and Retrofit.

Based on Technology, the Grow Light Market studied across Fluorescent Lighting, High-intensity Discharge, and LED.

Based on Spectrum, the Grow Light Market studied across Full-spectrum and Partial Spectrum.

Based on Watt, the Grow Light Market studied across <300 Watt and >300 Watt.

Based on Lighting Type, the Grow Light Market studied across Interlighting and Toplighting.

Based on Product, the Grow Light Market studied across Hardware and Software & Services.

Based on Application, the Grow Light Market studied across Greenhouse, Indoor Farming, Turf and Landscaping, and Vertical Farming.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Grow Light Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Grow Light Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Grow Light Market including Aerofarms, Bowery Farming, Inc., California Lightworks, Crop One Holdings, Emium LLC, Epistar Corporation, Everlight Electronics Co. Ltd, Gavita International B.V., General Electric Company, Heliospectra AB, Hortilux Schreder B.V, Hydro Grow, Illumitex Inc., Indulux Technologies, Iwasaki Electric Co. Ltd, Kessil, LumiGrow, Inc., Metropolis Farms, Osram Gmbh, OSRAM Licht AG, Platinum LED Lights LLC, Royal Philips, Savant Systems Inc., Signify Holding, Sunlight Supply, Thrive Agritech, Valoya, Vividgro, and Zuzi Technology.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Grow Light Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Grow Light Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Grow Light Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Grow Light Market?4. What is the competitive strategic window for opportunities in the Global Grow Light Market?5. What are the technology trends and regulatory frameworks in the Global Grow Light Market?6. What are the modes and strategic moves considered suitable for entering the Global Grow Light Market?Read the full report: https://www.reportlinker.com/p06015746/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more from the original source:

Grow Light Market Research Report by Installation, by Technology, by Spectrum, by Watt, by Lighting Type, by Product, by Application - Global Forecast...